...
首页> 外文期刊>Diseases of Aquatic Organisms >RNA interference-based therapeutics for shrimp viral diseases
【24h】

RNA interference-based therapeutics for shrimp viral diseases

机译:基于RNA干扰的虾类病毒性疾病治疗剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

RNA interference (RNAi) has emerged as a powerful tool to manipulate gene expression in the laboratory. The presence of a double-stranded RNA (dsRNA) in eukaryotic cells triggers this post-transcriptional gene-silencing mechanism, leading to a sequence-specific degradation of the target mRNA. Among its many potential biomedical applications, silencing of viral genes stands out as a promising therapeutic strategy. Marine shrimp viral diseases, especially white spot disease (WSD), represents one of the most attractive targets for the development of therapeutic RNAi owing to its widespread economic impact, This review summarizes the current knowledge in the therapeutic application of RNAi for combating viral diseases in shrimp. The basic principles of RNAi are described, focusing on features important for its therapeutic manipulation. Subsequently, a stepwise strategy for the development of therapeutic RNAi is presented.
机译:RNA干扰(RNAi)已成为在实验室中操纵基因表达的强大工具。真核细胞中双链RNA(dsRNA)的存在会触发这种转录后基因沉默机制,从而导致靶mRNA的序列特异性降解。在其许多潜在的生物医学应用中,病毒基因沉默是一种有前途的治疗策略。海洋虾病毒性疾病,特别是白斑病(WSD),由于其广泛的经济影响,代表了治疗性RNAi的发展中最有吸引力的目标之一。本综述总结了RNAi在抗击病毒性疾病中的治疗应用的最新知识。虾。描述了RNAi的基本原理,重点关注对其治疗操作重要的特征。随后,提出了开发治疗性RNAi的分步策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号